GL1X · GenesisL1 explorer

Ligand · MS7

MS7 · O-benzyl-N-methyl-L-tyrosinamide

MS7, O-benzyl-N-methyl-L-tyrosinamide (C17 H20 N2 O2, 284.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands…

Component
MS7
Formula
C17 H20 N2 O2
Class
ligand
Structures
2
PDB entries
1

Binding sites

MS7 in 2 structures; the first of them:

  • 3MSS · Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate site · MS7 A516 · binds ALA337, VAL338, LEU340, LEU341, ALA344, LEU429, ILE432, ALA433 and 3 more
  • 3MSS · Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate site · MS7 A516 · binds ALA337, VAL338, LEU340, LEU341, ALA344, LEU429, ILE432, ALA433 and 3 more

Residues it binds most

ALA 8, LEU 8, VAL 8, ILE 8, MET 8, PRO 8 (residue and the binding sites it lines).

Found with

  • STI · 4-(4-methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.